Emma Biegacki, MPH

Ms. Biegacki is a public health professional experienced in program and grants management, evaluation, and strategic planning. She is invested in improving wellbeing for people who use drugs and those with substance use disorder through community-led policy-and-practice reform. Biegacki has served as Program Manager of the Yale Program in Addiction Medicine since 2019, where she oversees day-to-day operations, communications, and organizational strategy spanning clinical practice, education, research, policy, and community engagement initiatives. In addition to serving as Project Director for the National Methadone Access and Quality Commission (NMAQC), she coordinates the Collaborative Behavioral Health and Addiction Medicine in Primary Care (CHAMP) and Substance Use Skills Training to Advance INtegrated Care (SUSTAIN) programs. She is co-author of the Connecticut Opioid Response (CORE) Initiative 2024 Report advising the Connecticut Opioid Settlement Advisory Committee on evidence-based spending of opioid settlement funds and has contributed to research published by JAMA Network Open, Journal of Addiction Medicine, Substance Use and Addiction, BMC Public Health, Harm Reduction, among other journals. Ms. Biegacki supports a wide array of other projects in collaboration with Yale Schools of Medicine and Public Health colleagues as well as local, state, and national partners.